MedPath

Cytaneon

Brand Name: Cytaneon

Generic Name: Cytarabine

Active
Registration Number

DRP-6653

Dosage Form

Solution For Injection (Iv)

Issuance Date

April 1, 2025

Expiry Date

April 22, 2038

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg/mL (1 g/10mL)
Packaging10 mL USP Type I flint glass vial with blue coloured flip-off seal (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

CytarabineActive
Monograph: Cytarabine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform